Sevoflurane + Desflurane + Rocuronium + Neostigmine + Glycopyrrolate
ApprovedCompleted 0 watching 0 views this week🔥 Hot
82
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Airway Reflexes, Protective
Conditions
Airway Reflexes, Protective, Recovery After Neuromuscular Block, Anesthetic Recovery
Trial Timeline
Aug 1, 2010 → Aug 1, 2013
NCT ID
NCT01199237About Sevoflurane + Desflurane + Rocuronium + Neostigmine + Glycopyrrolate
Sevoflurane + Desflurane + Rocuronium + Neostigmine + Glycopyrrolate is a approved stage product being developed by Baxter for Airway Reflexes, Protective. The current trial status is completed. This product is registered under clinical trial identifier NCT01199237. Target conditions include Airway Reflexes, Protective, Recovery After Neuromuscular Block, Anesthetic Recovery.
Hype Score Breakdown
Clinical
30
Activity
20
Company
7
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01199237 | Approved | Completed |
Competing Products
6 competing products in Airway Reflexes, Protective
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| fospropofol + fospropofol + fospropofol + fospropofol | Eisai | Pre-clinical | 23 |
| Levalbuterol HCl Inhalation Solution + Levalbuterol HCl Inhalation Solution + Albuterol HCl Inhalation Solution | Sumitomo Pharma | Phase 3 | 77 |
| Formoterol/Budesonide + lactose | AstraZeneca | Phase 2 | 52 |
| Tiotropium 'Respimat' 5 mcg + Aclidinium Bromide/Formoterol Fumarate 340/12 mcg | AstraZeneca | Approved | 85 |
| fluticasone propionate + Comparator: Placebo to fluticasone + Comparator: Lipopolysaccharide (LPS) + Comparator: albuterol | Merck | Phase 1 | 33 |
| Desloratadine + Placebo | Organon | Approved | 80 |